IPO

Aptus Pharma Limited IPO

BSE SME

Listed On: Sep 30, 2025 at ₹ 80.80

₹ 280000 /4000 Shares
*Min Investment

Check Allotment

23 Sep, 2025

Open Date

25 Sep, 2025

Close Date

26 Sep, 2025

Allotment Date

30 Sep, 2025

Listing Date
Aptus Pharma IPO Live Subscription Details
View Subscription Details
QIB 1.24x
Retail 31.54x
NIIs 29.11x
BHNI 31.17x
SHNI 24.93x
Retail 31.54x
Total 22.40x
Last updated: 25 Sep 2025, 06:55 PM
Aptus Pharma IPO Issue Details
  • Issue Price ₹65-70 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 18,60,000 shares(aggregating up to ₹13.02 crore)
  • Fresh Share 18,60,000 shares(aggregating up to ₹13.02 crore)
  • Listing at BSE SME
  • List Price 80.80
  • Listing Date 2025-09-30
  • Lead Manager Interactive Financial Services Ltd.
  • Registrar Bigshare Services Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 4,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)24,000₹2,80,000
Retail(max)24,000₹2,80,000
SHNI(min) 36,000₹4,20,000
SHNI(max) 714,000₹9,80,000
BHNI(min) 816,000₹11,20,000
Aptus Pharma IPO Reservation

Aptus Pharma IPO offers total 18,60,000 shares. Out of which 3,52,000 (18.92%) allocated to QIB, 2,66,000 (14.3%) allocated to NII,6,20,000 (33.33%) allocated to RII, NA (NA%) allocated to employees and 5,28,000 (28.39%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares Offered5,28,000 (28.39%)
Market Maker Shares Offered94,000 (5.05%)
QIB Shares Offered3,52,000 (18.92%)
NII (HNI) Shares Offered2,66,000 (14.3%)
bNII < ₹10L178,000 (9.6%)
sNII < ₹10L88000 (4.81%)
Retail Shares Offered6,20,000 (33.33%)
Total Shares Offered18,60,000 (100%)
Aptus Pharma IPO Documents
Aptus Pharma IPO Details


Aptus Pharma Limited IPO is an SME IPO, priced at ₹65-70 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 18,60,000 equity shares, aggregating up to ₹13.02 crores..

The IPO bidding window is open from Sep 23, 2025 to Sep 25, 2025. The allotment is expected to be finalized on Sep 26, 2025, and the tentative listing date is Sep 30, 2025.

The minimum lot size for Retail investors is 4,000 shares, with a minimum investment of ₹2,80,000.

Interactive Financial Services Ltd. is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and Market-Hub Stock Broking Pvt.Ltd. will act as the market maker for this issue.

Read More
Aptus Pharma IPO Subscription Analysis And Details
Retail
31.43x
Total
22.27x
As onQIB / NIIRetailTotal
Shares Offered / Reserved3,52,000 / 2,66,0006,20,00012,38,000
Day 1 23-09-25 06:00 PM
0.00 / 4.78 x1.77 x1.92 x
Day 2 24-09-25 06:00 PM
0.81 / 6.16 x5.46 x4.29 x
Day 3 25-09-25 06:00 PM
1.24 / 28.75 x31.43 x22.27 x

Total No of Applications
5,990
Aptus Pharma Valuations
EPS Pre IPO ₹6.20
EPS Post IPO ₹4.52
P/E Pre IPO 11.29
P/E Post IPO 15.49
ROE 44.50%
ROCE 45.66%
Debt/Equity 1.49
RoNW 44.50%
EBITDA Margin 19.31%
Aptus Pharma Company Financials
In Crs.
In Cr.
31-Mar-2531-Mar-2431-Mar-23
Assets21.9210.036.22
Revenue24.6417.8813.90
Profit After Tax3.100.800.19
Net Worth6.971.770.97
Reserves & Surplus1.971.470.67
Total Borrowing10.365.312.21
About Aptus Pharma Company

Established in 2010, Aptus Pharma Ltd is a company dealing with marketing, and distribution of finished pharmaceutical formulations. The company deals with manufacturers and distributors of a wide range of pharmaceutical formulations catering to various therapeutic categories: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, etc. Products: Aptus Pharma: Deals with acute therapies i.e, anti-infectives, pain management, etc. Aptus CD care: Deals with chronic therapies. Aptus Wellcare: Wellness and nutraceutical products. Aptus Global: Export in overseas market. The company has 194 formulations of medicines in over eleven therapeutic segments as of March 31, 2025. Its warehouse is spread over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model has 125 direct and sub distributors and a sales force of 54 field staff. The company had 70 employees as of March 31, 2025.

Read More
Aptus Pharma - Promoter(s)

Tejash Maheshchandra Hathi

Chatrabhuj Vallabhbhai Butani

Kapilbhai Hasmukhbhai Chandarana

Ghanshyam Vinubhai Pansuriya

Milly Chetan Lalseta

Riddhish Natwarlal Tanna

Gaurang Rameshchandra Thakker

Kripaliben Mayank Thakker

Kunjal Piyushbhai Unadkat

Pre Issue Share Holding : 100%

Post Issue Share Holding : 72.89%

Aptus Pharma IPO - Issue Objectives
1

Capital Expenditure for Office Premises with furniture and Industrial Racks - ₹1.63 Cr

2

Working Capital - ₹8.00 Cr

3

General corporate purposes

Contact Details

Aptus Pharma

Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427

+91 76004 27827

info@aptuspharma.com

https://aptus-pharma.com/

Registrar Contact Details